- Home
- PMVP vs PETS Comparison
PMVP vs PETS Comparison
Compare PMVP & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- PETS
- Stock Information
- Founded
- PMVP 2013
- PETS 1996
- Country
- PMVP United States
- PETS United States
- Employees
- PMVP N/A
- PETS N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- PMVP Health Care
- PETS Consumer Staples
- Exchange
- PMVP Nasdaq
- PETS Nasdaq
- Market Cap
- PMVP 55.1M
- PETS 62.8M
- IPO Year
- PMVP 2020
- PETS N/A
- Fundamental
- Price
- PMVP $1.15
- PETS $3.40
- Analyst Decision
- PMVP Strong Buy
- PETS Sell
- Analyst Count
- PMVP 1
- PETS 2
- Target Price
- PMVP $5.00
- PETS $3.35
- AVG Volume (30 Days)
- PMVP 278.5K
- PETS 141.6K
- Earning Date
- PMVP 08-07-2025
- PETS 08-05-2025
- Dividend Yield
- PMVP N/A
- PETS N/A
- EPS Growth
- PMVP N/A
- PETS N/A
- EPS
- PMVP N/A
- PETS 0.02
- Revenue
- PMVP N/A
- PETS $247,010,000.00
- Revenue This Year
- PMVP N/A
- PETS N/A
- Revenue Next Year
- PMVP N/A
- PETS N/A
- P/E Ratio
- PMVP N/A
- PETS $192.80
- Revenue Growth
- PMVP N/A
- PETS N/A
- 52 Week Low
- PMVP $0.81
- PETS $2.90
- 52 Week High
- PMVP $1.82
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- PMVP 57.96
- PETS 39.83
- Support Level
- PMVP $0.96
- PETS $3.13
- Resistance Level
- PMVP $1.14
- PETS $3.44
- Average True Range (ATR)
- PMVP 0.07
- PETS 0.18
- MACD
- PMVP -0.00
- PETS -0.02
- Stochastic Oscillator
- PMVP 65.28
- PETS 29.63
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.